Financial Year |
March 31 2023 |
Monetary Funds |
807,456,431.06 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
992,497.54 |
Accounts Receivable |
956,958,458.94 |
Advances to Suppliers |
55,227,684.93 |
Other Receivables |
22,703,150.45 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
124,942,029.14 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
63,040,787.27 |
Other Current Assets |
83,120,851.42 |
Total Current Assets |
2,116,542,367.25 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
152,211,633.85 |
Long-term Equity Investment |
50,749,259.92 |
Investment Properties |
34,884,074.75 |
Fixed Assetes |
2,160,864,175.60 |
Under-construction Projects |
843,325,332.06 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,077,031,232.29 |
R&D expenses |
30,467,858.98 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
48,350,634.19 |
Deferred Income Tax Assets |
125,894,004.06 |
Other Non-Current Assets |
168,918,951.40 |
Sub-Total of Non-Current Assets |
4,903,955,627.73 |
Total Assets |
7,020,497,994.98 |
Short-Term Loans |
1,042,511,611.11 |
Trading Financial liabilities |
-- |
Notes Payable |
22,422,155.87 |
Accounts Payable |
347,704,074.60 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
25,431,946.43 |
Taxes Payable |
49,377,133.17 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
39,394,106.07 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
352,392,399.90 |
Other Current Liabilities |
2,674,731.69 |
Sub-Total of Current Liabilities |
1,923,967,317.05 |
Long-term Loans |
2,375,251,660.72 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
21,159,847.90 |
Deferred Income Tax Liabilities |
5,412,336.47 |
Other Non-Current Liabilities |
5,189,592.12 |
Sub-Total of Non-Current Liabilities |
2,502,914,663.64 |
Total Liabilities |
4,426,881,980.69 |
Paid-In Capital(Or Share Stock) |
614,362,928.00 |
Capital Surplus |
2,197,383,017.28 |
Surplus Reserve |
36,442,010.41 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-309,726,727.04 |
Minority Stockholder's Interest |
52,310,465.04 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,541,305,549.25 |
Owner's Equity(Stockholder's Equity) |
2,593,616,014.29 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,020,497,994.98 |